| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 181.90M | 214.47M | 256.88M | 466.75M | 428.74M |
| Gross Profit | 111.60M | 88.97M | 256.88M | 433.25M | 393.09M |
| EBITDA | 12.94M | 52.16M | 64.30M | 232.02M | 214.74M |
| Net Income | -33.70M | 5.84M | 20.60M | 156.45M | 155.72M |
Balance Sheet | |||||
| Total Assets | 11.16B | 10.67B | 9.26B | 12.33B | 14.44B |
| Cash, Cash Equivalents and Short-Term Investments | 3.07B | 4.50B | 4.64B | 3.81B | 3.09B |
| Total Debt | 5.53B | 89.32M | 4.96B | 5.23B | 6.58B |
| Total Liabilities | 10.47B | 9.86B | 8.48B | 11.46B | 13.64B |
| Stockholders Equity | 692.11M | 803.83M | 780.13M | 870.03M | 802.09M |
Cash Flow | |||||
| Free Cash Flow | 28.56M | -43.21M | -316.25M | -1.85B | 2.12B |
| Operating Cash Flow | 45.93M | -16.77M | -313.94M | -1.83B | 2.14B |
| Investing Cash Flow | -17.35M | -26.41M | -29.50M | -25.86M | -23.07M |
| Financing Cash Flow | -63.54M | -40.56M | -116.56M | -93.06M | -32.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | CHF2.02B | 6.19 | 27.64% | 2.36% | 9.07% | 18.07% | |
69 Neutral | CHF5.63B | 10.60 | ― | 1.22% | 18.76% | 20.08% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | CHF3.71B | 5.44 | 11.11% | 4.66% | 3.80% | 15.49% | |
61 Neutral | CHF2.73B | 15.41 | 5.75% | 3.88% | -12.47% | 2.74% | |
57 Neutral | CHF5.26B | 17.97 | 9.10% | 3.15% | -0.27% | 21.41% | |
47 Neutral | CHF260.92M | -7.17 | ― | 21.87% | -4.06% | -109.73% |
Raiffeisen Schweiz has sold a 22.7% stake in Leonteq AG to H21 Macro Limited and four private investors, reducing its holding to 7%, while leaving intact a long-standing cooperation agreement between the two groups that runs until 2030. The transaction, which remains subject to regulatory approvals and is expected to close by the third quarter of 2026, is seen by Leonteq’s board as a vote of confidence from professional investors and a step that should improve the liquidity of its shares.
Separately, Swiss regulator FINMA has confirmed that Leonteq Securities AG now qualifies as a bank-equivalent counterparty under the Swiss Capital Adequacy Ordinance, allowing partners to treat its counterparty risk in line with that of banks. This reclassification, combined with Leonteq’s reported strong CET1 capital ratio, enhances its risk and credit profile with hedging counterparties and white-labelling partners, reinforcing its positioning in the structured products market and supporting its strategic growth ambitions.
The most recent analyst rating on (CH:LEON) stock is a Sell with a CHF10.50 price target. To see the full list of analyst forecasts on Leonteq AG stock, see the CH:LEON Stock Forecast page.
Leonteq AG reported a 2025 loss as lower commission and service income and a weaker trading result outweighed significant cost cuts, although client activity recovered in the second half and transaction volumes rose. The company maintained a strong CET1 capital ratio of 16.9% after an early transition to a stricter regulatory regime and will propose Felix Oegerli as new independent chairman at the 2026 AGM.
Operating income fell to CHF 172.3 million from CHF 238.5 million, while underlying operating expenses dropped 16%, leading to an underlying pre-tax loss of CHF 21.5 million and an IFRS pre-tax loss of CHF 33.3 million. In line with its capital return policy, the board will skip a 2025 dividend and plans a share buyback from early 2027, while continuing to roll out new AMC offerings, grow its retail flow franchise and use BaFin licence extensions to drive revenue growth and a return to profitability.
Leonteq’s adoption of the SA-FRTB standardised market risk framework cut risk-weighted assets, lifted capital ratios above guidance and concluded regulatory discussions on a bespoke liquidity regime ahead of schedule. Management says the completed “resizing and optimisation” phase now allows a pivot to expansion, with a targeted improvement in recurring revenues, broader market reach and a new leadership structure intended to support meeting mid-term financial goals by 2028.
The most recent analyst rating on (CH:LEON) stock is a Hold with a CHF14.50 price target. To see the full list of analyst forecasts on Leonteq AG stock, see the CH:LEON Stock Forecast page.
Germany’s Federal Financial Supervisory Authority (BaFin) has granted Leonteq Securities (Europe) GmbH an extension to its licence, allowing it to support Leonteq Securities AG’s trading activities and paving the way for the rollout of its retail flow business in the German market. The initiative builds on Leonteq’s rapid expansion in Switzerland, where it now offers more than 10,000 exchange-listed leveraged products on SIX and BX Swiss, has captured a 7% product market share on SIX within eight months, and ranks first in the Payoff Market Making Index for execution quality; management describes the retail flow push as Leonteq’s largest recent investment and a key milestone in its strategy to become a leading issuer of exchange-traded structured products beyond Switzerland, with German investors set to gain direct access to its technology-driven platform and local expertise.
The most recent analyst rating on (CH:LEON) stock is a Hold with a CHF14.50 price target. To see the full list of analyst forecasts on Leonteq AG stock, see the CH:LEON Stock Forecast page.
Leonteq AG has completed its transition to the SA-FRTB regulatory framework, achieving a CET1 ratio of over 15% by November 2025. Despite improvements in customer activity, the company anticipates an underlying loss for the year due to reduced hedging contributions. The company has made strides in restoring customer confidence and expanding its revenue base, although it remains sensitive to market conditions. Leonteq is also undergoing strategic changes, including selling its Japan branch and increasing its Lisbon service center workforce, aiming to reduce costs and improve profitability.
The most recent analyst rating on (CH:LEON) stock is a Hold with a CHF15.00 price target. To see the full list of analyst forecasts on Leonteq AG stock, see the CH:LEON Stock Forecast page.